The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: Implications for viral persistence

Journal of Infectious Diseases

Volumn 208, Issue 8, 2013, Pages 1212-1220

  Yukl, Steven A ^a   Shergill, Amandeep K ^a   Ho, Terence ^a   Killian, Maudi ^a   Girling, Valerie ^a   Epling, Lorrie ^a   Li, Peilin ^a   Wong, Lisa K ^b   Crouch, Pierre ^a   Deeks, Steven G ^a   Havlir, Diane V ^a   McQuaid, Kenneth ^a   Sinclair, Elizabeth ^a   Wong, Joseph K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ART; CD4+ T cell; gut; HIV; HIV 1; ileum; intestine; persistence; rectum; reservoir

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; CD27 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR7; EFAVIRENZ; EMTRICITABINE; LAMIVUDINE; LOPINAVIR; RITONAVIR; TENOFOVIR; VIRUS DNA; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD; CD4+ T LYMPHOCYTE; CELL LEVEL; CELL SELECTION; CELL TYPE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; DENDRITIC CELL; EFFECTOR CELL; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILEUM; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MALE; MEMORY T LYMPHOCYTE; MONOCYTE; NATURAL KILLER CELL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; RECTUM; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; VIRUS VIRULENCE;

ART; CD4+ T CELL; GUT; HIV; HIV-1; ILEUM; INTESTINE; PERSISTENCE; RECTUM; RESERVOIR;

ADULT; ANTI-RETROVIRAL AGENTS; CD4-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; FLOW CYTOMETRY; HIV; HIV INFECTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; RNA, VIRAL; STATISTICS, NONPARAMETRIC; VIRAL LOAD;

EID: 84885038080     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit308     Document Type: Article

References (43)

1. Schockmel GA, Yerly S, Perrin L. Detection of low HIV-1 RNA levels in plasma. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:179-83.
2. Dornadula G, Zhang H, VanUitert B, et al. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA 1999; 282:1627-32.
3. Havlir DV, Bassett R, Levitan D, et al. Prevalence and predictive value of intermittent viremia with combination HIV therapy. JAMA 2001; 286:171-9.
4. Maldarelli F, Palmer S, King MS, et al. ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathog 2007; 3:e46.
5. Chun TW, Carruth L, Finzi D, et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997; 387:183-8.
6. Chun TW, Stuyver L, Mizell SB, et al. Presence of an inducible HIV latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 1997; 94:13193-7.
7. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295-300.
8. Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replicationcompetent HIV despite prolonged suppression of plasma viremia. Science 1997; 278:1291-5.
9. Fischer M, Huber W, Kallivroussis A, et al. Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissues. J Clin Microbiol 1999; 37:1260-4.
10. Fischer M, Wong JK, Russenberger D, et al. Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts. Antivir Ther 2002; 7:91-103.
11. Lafeuillade A, Poggi C, Profizi N, Tamalet C, Costes O. Human immunodeficiency virus type 1 kinetics in lymph nodes compared with plasma. J Infect Dis 1996; 174:404-7.
12. Cavert W, Notermans DW, Staskus K, et al. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 1997; 276:960-4.
13. Wong JK, Gunthard HF, Havlir DV, et al. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A 1997; 94:12574-9.
14. Kuster H, Opravil M, Ott P, et al. Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection. Am J Pathol 2000; 156:1973-86.
15. Talal AH, Monard S, Vesanen M, et al. Virologic and immunologic effect of antiretroviral therapy on HIV-1 in gut-associated lymphoid tissue. J Acquir Immune Defic Syndr 2001; 26:1-7.
16. Guadalupe M, Reay E, Sankaran S, et al. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J Virol 2003; 77:11708-17.
17. Anton PA, Mitsuyasu RT, Deeks SG, et al. Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects. AIDS 2003; 17:53-63.
18. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-59.
19. Poles MA, Boscardin WJ, Elliott J, et al. Lack of decay of HIV-1 in gutassociated lymphoid tissue reservoirs in maximally suppressed individuals. J Acquir Immune Defic Syndr 2006; 43:65-8.
20. Belmonte L, Olmos M, Fanin A, et al. The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART. AIDS 2007; 21: 2106-8.
21. Chun TW, Nickle DC, Justement JS, et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis 2008; 197:714-20.
22. Avettand-Fenoel V, Prazuck T, Hocqueloux L, et al. HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors. AIDS 2008; 22:1880-2.
23. Lafeuillade A, Cheret A, Hittinger G, et al. Rectal cell-associated HIV-1 RNA: A new marker ready for the clinic. HIV Clin Trials 2009; 10: 324-7.
24. Tincati C, Biasin M, Bandera A, et al. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection. Antiviral Ther 2009; 14:321-30.
25. Yukl SA, Gianella S, Sinclair E, et al. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis 2010; 202:1553-61.
26. Chun TW, Finzi D, Margolick J, Chadwick K, Schwartz D, Siliciano RF. In vivo fate of HIV-1 infected T cells: Quantitative analysis of the transition to stable latency. Nature Medicine 1995; 1:1284-90.
27. Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 2008; 6:388-400.
28. Haase AT, Henry K, Zupancic M, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 1996; 274:985-9.
29. Brenchley JM, Hill BJ, Ambrozak DR, et al. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: Implications for HIV pathogenesis. J Virol 2004; 78:1160-8.
30. Gosselin A, Monteiro P, Chomont N, et al. Peripheral blood CCR4 +CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection. J Immun 2010; 184:1604-16.
31. Monteiro P, Gosselin A, Wacleche VS, et al. Memory CCR6+CD4+ T cells are preferential targets for productive HIV type 1 infection regardless of their expression of integrin beta7. J Immun 2011; 186: 4618-30.
32. Tran TA, de Goer de Herve MG, Hendel-Chavez H, et al. Resting regulatory CD4 T cells: A site of HIV persistence in patients on long-term effective antiretroviral therapy. PLoS ONE 2008; 3:e3305.
33. Chomont N, El-Far M, Ancuta P, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009; 15:893-900.
34. Fischer M, Joos B, Niederost B, et al. Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy. Retrovirology 2008; 5:107.
35. Kumar AM, Borodowsky I, Fernandez B, Gonzalez L, Kumar M. Human immunodeficiency virus type 1 RNA levels in different regions of human brain: Quantification using real-time reverse transcriptasepolymerase chain reaction. J Neurovirol 2007; 13:210-24.
36. Macallan DC, Wallace D, Zhang Y, et al. Rapid turnover of effectormemory CD4+ T cells in healthy humans. J Exp Med 2004; 200: 255-60.
37. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
38. Rivino L, Messi M, Jarrossay D, Lanzavecchia A, Sallusto F, Geginat J. Chemokine receptor expression identifies pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J Exp Med 2004; 200:725-35.
39. Baron V, Bouneaud C, Cumano A, et al. The repertoires of circulating human CD8(+) central and effector memory T cell subsets are largely distinct. Immunity 2003; 18:193-204.
40. Geginat J, Sallusto F, Lanzavecchia A. Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4+ T cells. J Exp Med 2001; 194:1711-9.
41. Lanzavecchia A, Sallusto F. Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2002; 2:982-7.
42. Gulzar N, Diker B, Mihowich J, et al. Proportion of HIV-1 infected CD8+CD4- T lymphocytes in vivo. Curr HIV Res 2008; 6:585-96.
43. Yukl SA, Shergill AK, McQuaid K, et al. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS 2010; 24:2451-60.